Literature DB >> 16715018

Evaluating treatment effectiveness: benchmarks for rehabilitation after partial meniscectomy knee arthroscopy.

Matthew C Morrissey1, Peter Milligan, Peter C Goodwin.   

Abstract

OBJECTIVE: The purpose of this study was to give a detailed description of recovery benchmarks that occur in patients whose therapy after partial meniscectomy knee arthroscopy consists of a home program of exercise. These benchmarks can be used as a basis for clinicians to compare improvements to individual patients who receive supervised care.
DESIGN: Thirty-nine patients (five females, mean age = 41) who underwent an uncomplicated arthroscopic partial meniscectomy were included. Test sessions occurred at 5 and 50 days after surgery. Outcome measures included: 1) Hughston Clinic knee self-assessment questionnaire; 2) EQ-5D Tariff for assessment of quality of life; 3) number of days taken to return to work after surgery; 4) knee passive range of motion; and 5) knee swelling assessed by evaluation of knee circumference. Stepwise regression analysis was used to evaluate factors that might have influenced the amount of pre- to posttest change in the outcome measures (the benchmarks) during the first 7 wks after surgery. The factors used in this analysis were: 1) age, 2) body mass index, 3) period from injury to surgery, and 4) the baseline value of the variable to be examined (except for return to work, where we used a score estimating the challenge to the knee offered by work).
RESULTS: None of the factors considered (age, body mass index, period from injury to surgery, stressfulness of the work on the knee) affected the number of days taken to return to work. Baseline scores affected change in all the other outcomes, and knee girth change was also affected by body mass index. Regression equations are presented where suitable for the benchmarks presented.
CONCLUSIONS: Quick recovery occurs in these patients when only a home exercise program is given. This paper highlights the utility of using historical control group data instead of test-retest analysis of measurement error in evaluating patients whose recovery with a home exercise program is rapid. Of the variables analyzed in this study, quality of life and knee self-assessment changes offer the most useful benchmarks for evaluating treatment effectiveness.

Entities:  

Mesh:

Year:  2006        PMID: 16715018     DOI: 10.1097/01.phm.0000219280.06297.bd

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  5 in total

1.  A randomized trial of isokinetic versus isotonic rehabilitation program after arthroscopic meniscectomy.

Authors:  Georgios Koutras; Magdalini Letsi; Pericles Papadopoulos; Ioannis Gigis; Evangelos Pappas
Journal:  Int J Sports Phys Ther       Date:  2012-02

2.  Effect of early active range of motion rehabilitation on outcome measures after partial meniscectomy.

Authors:  Brent M Kelln; Christopher D Ingersoll; Susan Saliba; Mark D Miller; Jay Hertel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-03-12       Impact factor: 4.342

3.  Cartilage degeneration and not age influences the health-related quality of life outcome after partial meniscectomy.

Authors:  Michael C Liebensteiner; Michael Nogler; Johannes M Giesinger; Ricarda Lechner; Florian Lenze; Martin Thaler
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-24       Impact factor: 4.342

4.  Health-related quality of life of day-case surgery patients: a pre/posttest survey using the EuroQoL-5D.

Authors:  Riitta Suhonen; Heli Virtanen; Katja Heikkinen; Kirsi Johansson; Anne Kaljonen; Tiina Leppänen; Sanna Salanterä; Helena Leino-Kilpi
Journal:  Qual Life Res       Date:  2007-12-12       Impact factor: 4.147

5.  Is postoperative exercise therapy necessary in patients with degenerative meniscus? A randomized controlled trial with one year follow-up.

Authors:  Håvard Østerås; Berit Østerås; Tom Arild Torstensen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-12-23       Impact factor: 4.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.